• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab.

作者信息

Simkens L H J, Tol J, Terstappen L W M M, Teerenstra S, Punt C J A, Nagtegaal I D

机构信息

Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen.

Department of Medical Cell Biophysics, Faculty of Sciences and Technology, Twente University, Enschede.

出版信息

Ann Oncol. 2010 Dec;21(12):2447-2448. doi: 10.1093/annonc/mdq640. Epub 2010 Oct 28.

DOI:10.1093/annonc/mdq640
PMID:21030382
Abstract
摘要

相似文献

1
The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab.循环内皮细胞在接受一线化疗和贝伐单抗治疗的晚期结直肠癌患者中的预测和预后价值。
Ann Oncol. 2010 Dec;21(12):2447-2448. doi: 10.1093/annonc/mdq640. Epub 2010 Oct 28.
2
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients.循环内皮细胞和内皮祖细胞作为贝伐珠单抗一线治疗晚期结直肠癌患者临床反应的预测标志物。
Ann Oncol. 2010 Dec;21(12):2382-2389. doi: 10.1093/annonc/mdq261. Epub 2010 May 23.
3
Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer.检测外周血中KRAS癌基因作为转移性结直肠癌患者对西妥昔单抗联合化疗反应的预测指标。
Clin Cancer Res. 2009 Jul 1;15(13):4508-13. doi: 10.1158/1078-0432.CCR-08-3179. Epub 2009 Jun 23.
4
Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.在晚期结直肠癌中，将抗血管内皮生长因子A（VEGF-A）人源化单克隆抗体贝伐单抗与化疗联合应用。
Clin Colorectal Cancer. 2004 Oct;4 Suppl 2:S62-8. doi: 10.3816/ccc.2004.s.010.
5
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.一线化疗联合贝伐珠单抗治疗转移性结直肠癌患者循环内皮细胞水平的临床价值。
Ann Oncol. 2012 Apr;23(4):919-27. doi: 10.1093/annonc/mdr365. Epub 2011 Aug 8.
6
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab.循环肿瘤细胞联合 KRAS 对化疗联合贝伐珠单抗治疗转移性结直肠癌患者预后的预测价值。
Clin Colorectal Cancer. 2013 Dec;12(4):280-6. doi: 10.1016/j.clcc.2013.06.001. Epub 2013 Sep 5.
7
A phase III randomized, open-label, controlled trial of chemotherapy and bevacizumab with or without panitumumab in the first-line treatment of patients with metastatic colorectal cancer.一项关于化疗和贝伐单抗联合或不联合帕尼单抗用于转移性结直肠癌患者一线治疗的III期随机、开放标签、对照试验。
Clin Colorectal Cancer. 2006 Jan;5(5):363-7. doi: 10.3816/CCC.2006.n.008.
8
EGFR antibodies in colorectal cancer: where do they belong?结直肠癌中的表皮生长因子受体抗体：它们的归属在哪里？
J Clin Oncol. 2010 Nov 1;28(31):4668-70. doi: 10.1200/JCO.2010.29.3407. Epub 2010 Oct 4.
9
Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.转移性结直肠癌（mCRC）中抗血管生成治疗的生物标志物：原始数据及文献综述
Z Gastroenterol. 2011 Oct;49(10):1398-406. doi: 10.1055/s-0031-1281752. Epub 2011 Sep 30.
10
[Utilizing synergism].[利用协同作用]
Krankenpfl J. 2005;43(4-6):145.

引用本文的文献

1
Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy.新辅助化疗后局部晚期乳腺癌患者中具有预后价值的非整倍体循环内皮细胞
Breast Cancer (Dove Med Press). 2024 Nov 12;16:761-768. doi: 10.2147/BCTT.S487336. eCollection 2024.
2
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics.细胞状态与细胞类型：通过多组学技术解析液体活检中的循环肿瘤细胞群体
Cancers (Basel). 2023 Aug 3;15(15):3949. doi: 10.3390/cancers15153949.
3
Defining A Liquid Biopsy Profile of Circulating Tumor Cells and Oncosomes in Metastatic Colorectal Cancer for Clinical Utility.
定义转移性结直肠癌中循环肿瘤细胞和肿瘤小体的液体活检特征以用于临床应用。
Cancers (Basel). 2022 Oct 6;14(19):4891. doi: 10.3390/cancers14194891.
4
Comprehensive Atlas of Circulating Rare Cells Detected by SE-iFISH and Image Scanning Platform in Patients With Various Diseases.通过SE-iFISH和图像扫描平台检测各种疾病患者循环稀有细胞的综合图谱
Front Oncol. 2022 Mar 2;12:821454. doi: 10.3389/fonc.2022.821454. eCollection 2022.
5
Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer.内皮细胞衍生的细胞外囊泡与转移性结直肠癌的不良预后相关。
Cells. 2020 Dec 15;9(12):2688. doi: 10.3390/cells9122688.
6
The Blood Circulating Rare Cell Population. What is it and What is it Good For?循环血液稀有细胞群体。它是什么，有什么用？
Cells. 2020 Mar 25;9(4):790. doi: 10.3390/cells9040790.
7
CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer.CD276 阳性循环内皮细胞不能预测晚期结直肠癌患者对系统治疗的反应。
Cells. 2020 Jan 5;9(1):124. doi: 10.3390/cells9010124.
8
Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma.散发性结直肠癌IV期的微卫星不稳定性与血管生成表现
Medicine (Baltimore). 2019 Jan;98(1):e13956. doi: 10.1097/MD.0000000000013956.
9
Prognostic value of circulating endothelial cells in metastatic colorectal cancer.循环内皮细胞在转移性结直肠癌中的预后价值。
Oncotarget. 2017 Jun 6;8(23):37491-37501. doi: 10.18632/oncotarget.16397.
10
Challenges in circulating tumor cell detection by the CellSearch system.CellSearch系统在循环肿瘤细胞检测中的挑战。
Mol Oncol. 2016 Mar;10(3):395-407. doi: 10.1016/j.molonc.2015.12.002. Epub 2015 Dec 25.